Quantitative MRI Reading: Applications in Prostate Cancer

How to cite: Bird, Victoria Y. Quantitative MRI Reading: Applications in Prostate Cancer. Grand Rounds in Urology. September 15, 2025. Accessed Apr 2026. https://grandroundsinurology.com/quantitative-mri-reading-applications-in-prostate-cancer/

Summary

Victoria Y. Bird, MD, Assistant Professor, Department of Urology, University of Florida, Gainesville, Florida, introduces quantitative magnetic resonance imaging (MRI) as a tool that may provide standardized, objective measures of prostate tissue characteristics, potentially reducing variability between readers and institutions. She notes that while multiparametric MRI is established in prostate cancer care, quantitative analysis could refine lesion characterization by offering reproducible metrics that may support more consistent biopsy targeting and patient monitoring.

Dr. Bird describes how quantitative MRI parameters, including apparent diffusion coefficient values and perfusion metrics, may help distinguish between indolent and clinically significant disease. She emphasizes the potential role of these imaging measures in reducing unnecessary biopsies while improving detection of aggressive cancer phenotypes.

She acknowledges challenges in implementing quantitative MRI broadly, including technical standardization, validation across diverse populations, and integration into clinical workflows. Dr. Bird notes that early data are promising but require further validation before widespread adoption.

Dr. Bird references the potential for quantitative MRI to support longitudinal disease monitoring, enabling more precise assessment of treatment response or disease progression. She shares that ongoing research will determine how these imaging approaches may complement established diagnostic tools and contribute to more personalized prostate cancer care.

The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multi-disciplinary forum organized to inform the key health care stakeholders about the emerging advances in clinical cases and research and create a consensus-based vision for the future of precision care and educational and research strategy for its realization. The mission of the Summit is to fill the currently existing gap between the key experts of in vivo imaging, the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics, and thought leaders in the development of novel observation strategies (e.g., active surveillance, or AS) and therapeutic interventions.